NeuroOne Medical Technologies Corporation (NMTC) financial statements (2022 and earlier)

Company profile

Business Address 7599 ANAGRAM DR
EDEN PRAIRIE, MN 55344
State of Incorp. DE
Fiscal Year End September 30
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q1
9/30/2021
Q4
6/30/2021
Q3
3/31/2021
Q2
12/31/2020
Q1
9/30/2020
Q4
6/30/2020
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments16,1846,9018,99111,2747,1294,0363,824
Cash and cash equivalents16,1846,9018,99111,2747,1294,0363,824
Receivables254840 71  
Inventory, net of allowances, customer advances and progress billings2299852 14  
Inventory2299852 14  
Prepaid expense1372441888112611980
Total current assets:16,5767,2929,27111,3557,3404,1553,904
Noncurrent Assets
Operating lease, right-of-use asset263289241255269282295
Property, plant and equipment217223156161153166101
Intangible assets, net (including goodwill)129134140145151157162
Intangible assets, net (excluding goodwill)129134140145151157162
Total noncurrent assets:608646537562573605558
TOTAL ASSETS:17,1837,9389,80911,9177,9134,7604,462
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,0601,1737337191,1311,2751,309
Accounts payable704529296346520763911
Accrued liabilities356644437374612513397
Debt     1,0076,728
Other undisclosed current liabilities2914315,05173 
Total current liabilities:1,0621,1827477506,1832,3568,037
Noncurrent Liabilities
Long-term debt and lease obligation173203207223239254269
Operating lease, liability173203207223239254269
Other undisclosed noncurrent liabilities(173)(203)(207)(140)(156)(171)(186)
Total noncurrent liabilities:173 20730732283353
Total liabilities:1,2361,3859541,0576,5052,6948,389
Stockholders' equity
Stockholders' equity attributable to parent15,9486,5548,85510,8601,4082,066(3,927)
Common stock40363636232218
Additional paid in capital59,54247,34547,00346,05734,22432,92326,368
Accumulated deficit(43,635)(40,827)(38,184)(35,232)(32,839)(30,879)(30,313)
Total stockholders' equity:15,9486,5548,85510,8601,4082,066(3,927)
TOTAL LIABILITIES AND EQUITY:17,1837,9389,80911,9177,9134,7604,462

Income statement (P&L) ($ in thousands)

12/31/2021
Q1
9/30/2021
Q4
6/30/2021
Q3
3/31/2021
Q2
12/31/2020
Q1
9/30/2020
Q4
6/30/2020
Q3
Revenues3448401871  
Cost of revenue(47)(65)(62)(39)(109)  
Gross profit:(13)(17)(22)(21)(38)  
Operating expenses(2,803)(2,632)(3,031)(2,395)(2,128)(2,044)(1,593)
Other undisclosed operating income651720221,927 
Operating loss:(2,809)(2,644)(3,035)(2,396)(2,143)(117)(1,593)
Nonoperating income  832185  
Interest and debt expense      (2,018)
Other undisclosed loss from continuing operations before equity method investments, income taxes (270)     
Loss from continuing operations before equity method investments, income taxes:(2,809)(2,914)(2,952)(2,394)(1,958)(117)(3,611)
Other undisclosed income (loss) from continuing operations before income taxes21  (1)6,271(3,480)
Income (loss) from continuing operations before income taxes:(2,807)(2,913)(2,952)(2,394)(1,959)6,154(7,091)
Other undisclosed income from continuing operations 271     
Income (loss) before gain (loss) on sale of properties:(2,807)(2,642)(2,952)(2,394)(1,959)6,154(7,091)
Other undisclosed net loss (1)   (6,720) 
Net loss available to common stockholders, diluted:(2,807)(2,643)(2,952)(2,394)(1,959)(566)(7,091)

Comprehensive Income ($ in thousands)

12/31/2021
Q1
9/30/2021
Q4
6/30/2021
Q3
3/31/2021
Q2
12/31/2020
Q1
9/30/2020
Q4
6/30/2020
Q3
Net loss:(2,807)(2,643)(2,952)(2,394)(1,959)(566)(7,091)
Comprehensive loss, net of tax, attributable to parent:(2,807)(2,643)(2,952)(2,394)(1,959)(566)(7,091)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: